Close-contact infection reported as China’s H7N9 tally reaches 49 | Lessons not learned: Insider threats in pathogen research | Senator requests NIH consider pricing issues in drug collaborations | CDC fights plague in Uganda with eye on bioterror threat | The fight to end pandemics | Researchers find salmonella to be more resistant than originally thought | The global distribution and burden of dengue | Making vaccine for new H7N9 virus could be a challenge, experts say | New cutting-edge research will lead to safer medical experiments on humans | Hospital preparedness program and Hurricane Sandy | Why chemotherapy that costs $75K in the U.S. costs $2,500 in India | New bird flu strain seen adapting to mammals, humans | U.S. Supreme Court to decide if companies can patent human genes | CDC preparedness funds take hit in proposed 2014 budget
See what we’re reading this week at Global Biodefense on topics like H7N9 influenza deaths in China, CDC preparedness budget, global dengue assessment and more…
Close-contact infection reported as China’s H7N9 tally reaches 49 (CIDRAP)
Lessons not learned: Insider threats in pathogen research (Bulletin Atomic Scientists)
Senator requests NIH consider pricing issues in drug collaborations (FLC Newslink)
CDC fights plague in Uganda with eye on bioterror threat (NTI GSN)
The fight to end pandemics (Forbes)
Researchers find salmonella to be more resistant than originally thought (Virginia Tech)
The global distribution and burden of dengue (Nature)
Making vaccine for new H7N9 virus could be a challenge, experts say (HuffPost Canada)
New cutting-edge research will lead to safer medical experiments on humans (USD)
Hospital preparedness program and Hurricane Sandy (PHE.gov)
Why chemotherapy that costs $75K in the U.S. costs $2,500 in India (The Atlantic)
New bird flu strain seen adapting to mammals, humans (Univ of Wisconsin-Madison)
U.S. Supreme Court to decide if companies can patent human genes (The Guardian)
CDC preparedness funds take hit in proposed 2014 budget (CIDRAP)
